EBOS Group on Tuesday reported FY26 revenue of A$13.5 billion, up 9.9% year-on-year, as the healthcare and animal care segments drove growth. Underlying EBITDA increased 5.0% to A$614 million, meeting guidance, while underlying net profit after tax fell 3.1% to A$250 million.
The company completed a four-year distribution center renewal program totaling A$360 million, with the new Perth facility now operational and expected to support national contract logistics from FY27. Capital expenditure peaked at A$145 million in FY26 and is forecast to normalize to approximately A$100 million in FY27, according to CFO Alistair Gray.
Healthcare revenue rose 8.5% to A$12.6 billion, with Terry White Chemmart’s network expanding by 86 stores to 780 locations. The animal care segment delivered the strongest growth, with revenue up 34.6% to A$907 million and underlying EBITDA rising 11.6%. Gross operating revenue margin compressed by 40 basis points to 12.9%, though operating expenditure improved by 20 basis points as a percentage of revenue.
Net debt-to-EBITDA stood at 2.1 times, within the target range of 1.7 to 2.3 times, with A$726 million in undrawn committed bank facilities available. The company deployed A$121 million across eight bolt-on acquisitions in FY26, leaving approximately A$150 million of M&A capacity to maintain leverage at 2.30 times.
FY27 guidance projects underlying EBITDA of A$635 million to A$655 million, with capex expected at A$100 million and net finance costs rising to A$138 million–A$148 million. CEO Adam Hall stated the group has completed a major phase of investment, transitioning focus toward earnings growth and cash flow generation.
Shares rose 5.5% to A$23 following the announcement, having recovered from a 52-week low of A$19.
